CardioGenics Holdings Inc (OTCMKTS:CGNH – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. CardioGenics shares last traded at $0.00, with a volume of 0 shares.
CardioGenics Stock Performance
CardioGenics Company Profile
CardioGenics Holdings Inc engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories.
Featured Stories
- Five stocks we like better than CardioGenics
- What is the FTSE 100 index?
- Oracle Announces Game-Changing News for the AI Industry
- What is diluted earnings per share (Diluted EPS)?
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- The Significance of Brokerage Rankings in Stock Selection
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for CardioGenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CardioGenics and related companies with MarketBeat.com's FREE daily email newsletter.
